Cargando…

Minimal graft site morbidity using autogenous semitendinosus graft from the uninjured leg: a randomised controlled trial

PURPOSE: To quantify the effect on strength of semitendinosus (ST) graft harvest by comparing isokinetic and isometric muscle strength. METHODS: A cohort of 140 patients underwent anterior cruciate ligament (ACL) reconstruction (ACLR) and were randomized to ipsilateral or contralateral ST graft harv...

Descripción completa

Detalles Bibliográficos
Autores principales: von Essen, Christoffer, McCallum, Sebastian, Eriksson, Karl, Barenius, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033693/
https://www.ncbi.nlm.nih.gov/pubmed/34368905
http://dx.doi.org/10.1007/s00167-021-06686-6
_version_ 1784692952606441472
author von Essen, Christoffer
McCallum, Sebastian
Eriksson, Karl
Barenius, Björn
author_facet von Essen, Christoffer
McCallum, Sebastian
Eriksson, Karl
Barenius, Björn
author_sort von Essen, Christoffer
collection PubMed
description PURPOSE: To quantify the effect on strength of semitendinosus (ST) graft harvest by comparing isokinetic and isometric muscle strength. METHODS: A cohort of 140 patients underwent anterior cruciate ligament (ACL) reconstruction (ACLR) and were randomized to ipsilateral or contralateral ST graft harvest. Isokinetic and isometric muscle strength testing using a dynamometer were collected for the operated and non-operated leg. Patients were assessed pre-surgery and at 6, 12 and 24 months after reconstruction. RESULTS: ST graft harvest reduced isokinetic flexion muscle strength for 6 months. At 12 months follow up there was no significant difference between the two groups and they were all stronger than pre-injury. No other significant differences were found in any primary or secondary outcome measurements. CONCLUSION: Solitary ST graft harvest does not appear to result in a permanent reduced isometric or isokinetic quadriceps muscle strength on the side where the graft is harvested. A reduction in hamstring muscle strength of less than 10% can be seen at short-term follow-up with full recovery by 12 months. Most patients report little or no donor site pain. Given these findings, ST autograft is an alternative graft choice that could be used for various reconstructions in terms of donor site morbidity. LEVEL OF EVIDENCE: Level II.
format Online
Article
Text
id pubmed-9033693
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-90336932022-05-06 Minimal graft site morbidity using autogenous semitendinosus graft from the uninjured leg: a randomised controlled trial von Essen, Christoffer McCallum, Sebastian Eriksson, Karl Barenius, Björn Knee Surg Sports Traumatol Arthrosc Knee PURPOSE: To quantify the effect on strength of semitendinosus (ST) graft harvest by comparing isokinetic and isometric muscle strength. METHODS: A cohort of 140 patients underwent anterior cruciate ligament (ACL) reconstruction (ACLR) and were randomized to ipsilateral or contralateral ST graft harvest. Isokinetic and isometric muscle strength testing using a dynamometer were collected for the operated and non-operated leg. Patients were assessed pre-surgery and at 6, 12 and 24 months after reconstruction. RESULTS: ST graft harvest reduced isokinetic flexion muscle strength for 6 months. At 12 months follow up there was no significant difference between the two groups and they were all stronger than pre-injury. No other significant differences were found in any primary or secondary outcome measurements. CONCLUSION: Solitary ST graft harvest does not appear to result in a permanent reduced isometric or isokinetic quadriceps muscle strength on the side where the graft is harvested. A reduction in hamstring muscle strength of less than 10% can be seen at short-term follow-up with full recovery by 12 months. Most patients report little or no donor site pain. Given these findings, ST autograft is an alternative graft choice that could be used for various reconstructions in terms of donor site morbidity. LEVEL OF EVIDENCE: Level II. Springer Berlin Heidelberg 2021-08-08 2022 /pmc/articles/PMC9033693/ /pubmed/34368905 http://dx.doi.org/10.1007/s00167-021-06686-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Knee
von Essen, Christoffer
McCallum, Sebastian
Eriksson, Karl
Barenius, Björn
Minimal graft site morbidity using autogenous semitendinosus graft from the uninjured leg: a randomised controlled trial
title Minimal graft site morbidity using autogenous semitendinosus graft from the uninjured leg: a randomised controlled trial
title_full Minimal graft site morbidity using autogenous semitendinosus graft from the uninjured leg: a randomised controlled trial
title_fullStr Minimal graft site morbidity using autogenous semitendinosus graft from the uninjured leg: a randomised controlled trial
title_full_unstemmed Minimal graft site morbidity using autogenous semitendinosus graft from the uninjured leg: a randomised controlled trial
title_short Minimal graft site morbidity using autogenous semitendinosus graft from the uninjured leg: a randomised controlled trial
title_sort minimal graft site morbidity using autogenous semitendinosus graft from the uninjured leg: a randomised controlled trial
topic Knee
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033693/
https://www.ncbi.nlm.nih.gov/pubmed/34368905
http://dx.doi.org/10.1007/s00167-021-06686-6
work_keys_str_mv AT vonessenchristoffer minimalgraftsitemorbidityusingautogenoussemitendinosusgraftfromtheuninjuredlegarandomisedcontrolledtrial
AT mccallumsebastian minimalgraftsitemorbidityusingautogenoussemitendinosusgraftfromtheuninjuredlegarandomisedcontrolledtrial
AT erikssonkarl minimalgraftsitemorbidityusingautogenoussemitendinosusgraftfromtheuninjuredlegarandomisedcontrolledtrial
AT bareniusbjorn minimalgraftsitemorbidityusingautogenoussemitendinosusgraftfromtheuninjuredlegarandomisedcontrolledtrial